Showing results (351-360 of 31,421) with videos related to
Sort By:
Pageof 3,143
Antimicrobial Agents and Chemotherapy|June 25, 2003
Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in GermanyRalf René Reinert, Angela Wild, Peter Appelbaum, et al.Antimicrobial Agents and Chemotherapy|June 25, 2003
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agentsManuel Cuenca-Estrella, Alicia Gomez-Lopez, Emilia Mellado, et al.Antimicrobial Agents and Chemotherapy|June 25, 2003
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compoundsMargarita Garau, Manolo Pereiro, Amalia del PalacioAntimicrobial Agents and Chemotherapy|June 25, 2003
In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacinLance B Price, Amy Vogler, Talima Pearson, et al.Antimicrobial Agents and Chemotherapy|June 25, 2003
Addition of caspofungin to fluconazole does not improve outcome in murine candidiasisJohn R Graybill, Rosie Bocanegra, Laura K Najvar, et al.Antimicrobial Agents and Chemotherapy|December 1, 1992
The role of guanosine-3',5'-bis-pyrophosphate in mediating antimicrobial activity of the antibiotic 3,5-dihydroxy-4-ethyl-trans-stilbeneL Sundar, F N ChangAntimicrobial Agents and Chemotherapy|November 1, 1992
Lesions and preferential initial localization of [S-methyl-3H]bleomycin A2 on Saccharomyces cerevisiae cell walls and membranesC W Moore, R Del Valle, J McKoy, et al.Antimicrobial Agents and Chemotherapy|March 26, 2003
Genetic basis for differential activities of fluconazole and voriconazole against Candida kruseiTakashi Fukuoka, Douglas A Johnston, Carol A Winslow, et al.Antimicrobial Agents and Chemotherapy|March 26, 2003
Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacinJeff N Anderl, Jeff Zahller, Frank Roe, et al.Antimicrobial Agents and Chemotherapy|March 26, 2003
Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infectionsCaroline Westwater, Laura M Kasman, David A Schofield, et al.Pageof 3,143